Genfit SA (GNFT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
October 2018
46
About the Report
About the Report
Summary
Genfit SA (Genfit) is a biopharmaceutical company that develops therapeutic and diagnostic solutions for metabolic and inflammatory diseases in liver and gastroenterology diseases. The company's pipeline products include GFT505, biomarkers, TGFTX1 and TGFTX4. Its TGFTX1 is a research program for auto-immune and inflammatory diseases; and TGFTX4 for fibrotic diseases. Genfit develops diagnostic solutions in various therapeutic areas such as metabolic diseases, liver diseases, non-alcoholic steatohepatitis, cholestatic liver diseases, inflammation and autoimmune diseases, and inflammatory bowel diseases. The company's research and development activities include multiple drug candidate research programs targeting novel mechanisms of action such as the inhibition of ROR?-t. It has presence in France and the US. Genfit is headquartered in Loos, France.
Genfit SA (GNFT)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Genfit SA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genfit SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genfit SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Genfit SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genfit SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Genfit SA, Medical Devices Deals, 2012 to YTD 2018 9
Genfit SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Genfit SA, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Genfit Enters into Agreement with Pinnacle Clinical Research Center 11
ImaBiotech Enters Into Agreement With Genfit 12
Equity Offering 13
Genfit Raises USD50 Million in Rights Offering of Shares 13
Genfit Raises USD38 Million Private Placement of Shares 14
Genfit Raises USD54.2 Million in Private Placement of Shares 15
Genfit Raises USD26 Million in Private Placement of Shares 16
Genfit Raises USD67.5 Million in Private Placement of Shares 17
Genfit Raises USD6.8 Million in Private Placement of Shares 18
Genfit Completes Private Placement Of Shares For USD 19 Million 19
Debt Offering 20
Genfit Raises USD212 Million in Private Placement of 3.5% Bonds Due 2022 20
Acquisition 21
Novartis May Acquire Genfit 21
Genfit SA-Key Competitors 22
Genfit SA-Key Employees 23
Genfit SA-Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Financial Announcements 25
Sep 24, 2018: GENFIT: 2018 Half-Year Results: Cash Position at End of Period at EUR238M and Significant Advances in the Clinical Development of Elafibranor 25
Apr 27, 2018: GENFIT: First quarter 2018 financial information 30
Oct 11, 2017: GENFIT: Third quarter 2017 financial information 31
Sep 25, 2017: Genfit: 2017 Half-Year Results: Cash Position At End Of Period At EUR126M And Significant Advances In The Company'S Pipeline 32
Apr 24, 2017: Genfit: Q1 2017 Financial Information 37
Corporate Communications 41
Sep 26, 2018: GENFIT: further details on management changes 41
Sep 24, 2018: GENFIT: Organizational Changes 42
Government and Public Interest 44
Apr 10, 2018: Vanderbilt scientists test potential new way to treat anemia 44
Product News 45
10/02/2017: GENFIT announces its participation at the 2017 AASLD Meeting 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46
List of Figure
List of Figures
Genfit SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Genfit SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Genfit SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Genfit SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Genfit SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genfit SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Genfit SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genfit SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Genfit SA, Medical Devices Deals, 2012 to YTD 2018 9
List of Table
List of Tables
Genfit SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Genfit SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genfit SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Genfit SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genfit SA, Deals By Therapy Area, 2012 to YTD 2018 8
Genfit SA, Medical Devices Deals, 2012 to YTD 2018 9
Genfit SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Genfit Enters into Agreement with Pinnacle Clinical Research Center 11
ImaBiotech Enters Into Agreement With Genfit 12
Genfit Raises USD50 Million in Rights Offering of Shares 13
Genfit Raises USD38 Million Private Placement of Shares 14
Genfit Raises USD54.2 Million in Private Placement of Shares 15
Genfit Raises USD26 Million in Private Placement of Shares 16
Genfit Raises USD67.5 Million in Private Placement of Shares 17
Genfit Raises USD6.8 Million in Private Placement of Shares 18
Genfit Completes Private Placement Of Shares For USD 19 Million 19
Genfit Raises USD212 Million in Private Placement of 3.5% Bonds Due 2022 20
Novartis May Acquire Genfit 21
Genfit SA, Key Competitors 22
Genfit SA, Key Employees 23
Genfit SA, Subsidiaries 24
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.